Idylla PIK3CA-AKT1 Mutation Assay (RUO)

A0171/6

The Idylla™ PIK3CA-AKT1 Mutation Assay, performed on the Biocartis Idylla™ System, is a fully automated real-time polymerase chain reaction (PCR) Assay for the qualitative detection of 13 mutations in the PIK3CA gene and one mutation in the AKT1 gene in formalin-fixed, paraffin-embedded (FFPE) human tissue sections. The Idylla™ PIK3CA- AKT1 Mutation Assay covers the entire process from FFPE sample to result, including fully integrated sample preparation, liberation of nucleic acids, real-time PCR amplification and detection, and data analysis.

DOWNLOAD LEAFLET DOWNLOAD TECHNICAL SHEET

Contact us for more information Request demo

For Research Use Only (RUO), not for use in diagnostic procedures.

Developed in collaboration with LifeArc.

PIK3CA

SPECIMEN REQUIREMENTS

  • 1x 5 μm FFPE tissue section if tissue area 50-600 mm²
  • 1x 10 μm FFPE tissue section if tissue area 25-300 mm²
  • Neoplastic cells ≥20% -  if less, macro-dissection is required

Discover all Breast Cancer Assays

breast_-_3_women.jpg